Latest drug prices and trends for NDC 46122-0719

Subscribe to access the full database, or Try for Free
Drug Name	NDC	Price/Unit ($)	Unit	Date
GNP NICOTINE 2 MG CHEWING GUM	46122-0719-60	0.23460	EACH	2025-04-23
GNP NICOTINE 2 MG CHEWING GUM	46122-0719-60	0.22311	EACH	2025-03-19
GNP NICOTINE 2 MG CHEWING GUM	46122-0719-60	0.22667	EACH	2025-02-19
GNP NICOTINE 2 MG CHEWING GUM	46122-0719-60	0.22252	EACH	2025-01-22
>Drug Name	>NDC	>Price/Unit ($)	>Unit	>Date

Subscribe to access the full database, or Try for Free

Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies
Drug Name	Vendor	NDC	Count	Price ($)	Price/Unit ($)	Dates	Price Type
No data available in table
>Drug Name	>Vendor	>NDC	>Count	>Price ($)	>Price/Unit ($)	>Dates	>Price Type

The pharmaceutical industry is constantly evolving, with drug prices and market trends playing a crucial role in shaping the landscape. In this comprehensive analysis, we'll delve into the market dynamics and price projections for the drug with National Drug Code (NDC) 46122-0719, examining various factors that influence its pricing and market position.

Understanding NDC 46122-0719

NDC 46122-0719 is a unique identifier assigned to a specific drug product. While the search results don't provide specific information about this particular NDC, we can analyze general trends and factors affecting drug pricing and market dynamics.

Current Market Landscape

The pharmaceutical market is experiencing significant changes, driven by various factors including technological advancements, regulatory shifts, and evolving patient needs. As we look towards 2025 and beyond, several key trends are emerging:

Technological Advancements

The integration of data, artificial intelligence (AI), and digital tools is revolutionizing the pharmaceutical industry. More than 85% of biopharma executives surveyed plan to invest in these technologies in 2025 to enhance various aspects of their operations, from research and development to supply chain management[7].

Focus on Novel Modalities

Pharmaceutical companies are increasingly adopting new modalities and mechanisms of action (MOAs) to redefine standards of care. This shift includes a focus on fusion proteins, oligonucleotide therapies, multispecific antibodies, and other emerging treatments[7].

Targeting High Unmet Needs

There's a growing emphasis on therapy areas (TAs) with high unmet needs. About half of the 10 largest pharma companies are expanding beyond traditional core areas like oncology and immunology[7].

Factors Influencing Drug Pricing

Understanding the factors that influence drug pricing is crucial for projecting future trends. Several key considerations come into play:

Patent Status and Market Exclusivity

The patent status of a drug significantly impacts its pricing. Brand-name drugs with patent protection can command higher prices due to market exclusivity[8].

Perceived Value and Unique Characteristics

Drug manufacturers consider the perceived value of a drug relative to its competitors, including factors such as ease of use, novelty, frequency of administration, and safety[8].

Alternative Treatments

The cost of therapeutically alternative drugs and other treatment options, such as surgery or medical devices, influences pricing decisions[8].

Market Size and Patient Characteristics

The size and characteristics of the patient market play a role in pricing strategies[8].

Research, Development, and Marketing Costs

Companies factor in the costs associated with bringing a drug to market, including research and development, manufacturing, and marketing expenses[8].

Third-Party Reimbursement

The amount of reimbursement available from third-party payers impacts pricing decisions[8].

Price Projections for 2025

While specific projections for NDC 46122-0719 are not available in the search results, we can analyze general trends in drug pricing:

Overall Drug Price Inflation

The overall drug price inflation rate for 2025 is projected to be 3.81%[10].

This projection provides a baseline for understanding potential price changes across the pharmaceutical industry.

Specific Drug Trends

Factors that may influence the price of NDC 46122-0719 in 2025 include:

Expanding indications
New formulations
Changes in manufacturing processes
Shifts in market demand
Regulatory changes

Impact of Technological Advancements

The increasing adoption of AI and digital tools in the pharmaceutical industry is expected to have a significant impact on drug development and pricing:

Accelerated R&D

AI-driven research and development could potentially reduce drug development costs and timelines. For instance, one top-10 pharma company expects to save approximately $1 billion in drug development costs over five years through the use of AI and digital tools[7].

Optimized Clinical Trials

Companies like Amgen have doubled their clinical trial enrollment speed using multimodal, data-driven machine learning tools[7]. This efficiency could potentially lead to faster drug approvals and market entry, influencing pricing strategies.

Enhanced Supply Chain Management

Over 85% of biopharma executives are investing in data, AI, and digital tools to build supply chain resiliency[7]. This could lead to more efficient production and distribution, potentially impacting drug pricing.

Market Strategies and Their Impact on Pricing

Pharmaceutical companies are adopting various strategies that could influence the pricing of drugs like NDC 46122-0719:

Portfolio Evolution

Many companies are diversifying their portfolios and focusing on specific therapy areas. This strategic shift could impact the pricing of individual drugs within a company's portfolio[7].

"Always Be Launching" Mindset

Some companies are moving away from reliance on blockbuster drugs and adopting an "always be launching" approach. For example, GSK expects to launch 12 new treatments in 2025[7]. This strategy could lead to more competitive pricing as companies seek to establish market share for multiple products.

Emphasis on Value-Based Pricing

As healthcare systems increasingly focus on outcomes, there's a growing trend towards value-based pricing. This approach ties the price of a drug to its demonstrated effectiveness, which could significantly impact pricing strategies for drugs like NDC 46122-0719.

Regulatory Environment and Its Impact on Pricing

The regulatory landscape plays a crucial role in shaping drug pricing:

Proposed Legislation

Potential changes in legislation, particularly in the United States, could impact drug pricing. Companies are preparing to address political changes to protect the continuity of their supply and pricing strategies[7].

Medicare Drug Price Negotiation Program

Beginning in January 2026, the first 10 negotiated prices are slated to go into effect in Medicare Part D. This program could have ripple effects across the industry, potentially influencing the pricing of drugs like NDC 46122-0719[2].

Global Economic Dynamics

The unpredictability of shifting global economic dynamics is pushing pharmaceutical companies to focus on self-sufficiency and expand their footprint in emerging markets[7]. This could lead to changes in pricing strategies across different regions.

Patient Assistance Programs

To mitigate high drug prices, some companies subsidize the price of their brand-name drugs through patient assistance programs[8]. The extent and nature of such programs for NDC 46122-0719 could influence its effective price for patients.

Key Takeaways

The overall drug price inflation rate for 2025 is projected to be 3.81%.
Technological advancements, particularly in AI and digital tools, are expected to significantly impact drug development, production, and potentially pricing.
Pharmaceutical companies are evolving their portfolios and adopting strategies like the "always be launching" mindset, which could influence individual drug pricing.
Regulatory changes, including the Medicare Drug Price Negotiation Program, may have substantial impacts on drug pricing strategies.
Global economic dynamics and the focus on emerging markets could lead to regional variations in pricing strategies.
Patient assistance programs continue to play a role in determining the effective price of drugs for consumers.

While specific projections for NDC 46122-0719 are not available, these industry-wide trends and factors will likely influence its pricing and market position in 2025 and beyond. Stakeholders should closely monitor these developments to make informed decisions and strategies.

FAQs

Q: What is an NDC code and why is it important? A: An NDC (National Drug Code) is a unique, three-segment number assigned by the FDA to human drugs in the United States. It's important because it helps identify the labeler, product, and trade package size of a drug, facilitating tracking and management in the healthcare system.
Q: How do pharmaceutical companies determine drug prices? A: Pharmaceutical companies consider various factors when setting drug prices, including the perceived value of the drug, its unique characteristics, alternative treatments, research and development costs, market size, and third-party reimbursement rates.
Q: What role does AI play in drug development and pricing? A: AI is increasingly used to accelerate drug development, optimize clinical trials, and enhance supply chain management. These efficiencies could potentially impact drug pricing by reducing development costs and time-to-market.
Q: How might the Medicare Drug Price Negotiation Program affect drug prices? A: The program, set to begin in 2026, could lead to lower prices for selected drugs in Medicare Part D. This could potentially have broader impacts on drug pricing strategies across the industry.
Q: What are some strategies pharmaceutical companies are using to adapt to changing market conditions? A: Companies are evolving their portfolios, focusing on high-unmet-need areas, adopting an "always be launching" mindset, investing in AI and digital tools, and expanding into emerging markets to adapt to changing market conditions.

Sources cited:

Drug Price Trends for NDC 46122-0719

Average Pharmacy Cost for 46122-0719

Best Wholesale Price for NDC 46122-0719

Market Analysis and Price Projections for NDC 46122-0719